Sponsor

MediciNova

Clinical research sponsor

Published trials9

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

9 shown

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaNCT05464784 · lead sponsor · 2022-08-22

ACTIVE_NOT_RECRUITING

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALSNCT04057898 · lead sponsor · 2020-05-28

ACTIVE_NOT_RECRUITING

A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS)NCT02714036 · lead sponsor · 2016-05-06

COMPLETED

Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple SclerosisNCT01982942 · lead sponsor · 2013-11-01

COMPLETED

Safety Study to Evaluate MN-221 in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01551316 · lead sponsor · 2012-03-01

COMPLETED

Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01013142 · lead sponsor · 2009-11-01

COMPLETED

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of AsthmaNCT00838591 · lead sponsor · 2009-03-01

COMPLETED

Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of AsthmaNCT00683449 · lead sponsor · 2008-06-01

TERMINATED

Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe AsthmaNCT00679263 · lead sponsor · 2008-02-01

COMPLETED

Sponsor roles

lead sponsor9

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.